| Trial registration number
|
NCT04504240 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04504240
|
First author
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MD
|
Contact
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
dr_mohiuddinchy@yahoo.com
|
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
2020-08-07
|
Recruitment status
Last imported at : Oct. 27, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
multi-center
|
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- sars-cov-2 infection confirmed by rt pcr or ct chest.
- severe covid-19 patients require hospitalization under hdu/icu.
|
Exclusion criteria
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- patients with severe and/or uncontrolled medical conditions with significantly
compromised organ function.
- patients who were hospitalized from the before due to other reasons.
- contraindication / possible drug interaction with famotidine with existing therapy.
- immunocompromised patients.
- pregnancy, pulmonary tuberculosis, aids
|
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Chattogram General Hospital
|
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
16
|
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
80
|
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Bangladesh
|
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Mild/moderate disease at enrollment
|
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
2: Mild/moderate disease at enrollment
|
Total sample size
Last imported at : Oct. 27, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
208
|
primary outcome
Last imported at : March 13, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Time to Clinical Improvement (TTCI);Time to symptomatic recovery.
|
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov
|
Phase 3
|
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "In an empty stomach", "treatment_id": 503, "treatment_name": "Famotidine", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Given with a PPI", "treatment_id": 503, "treatment_name": "Famotidine", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}]
|